EN
The aim of the study was to determine the potential prognostic significance of intratumoral microvessel density assessment with panendothelial marker CD34, a new and specific marker for new blood microvessels CD 105, and a potent angiogenesis modulator, epidermal growth factor receptor (EGF-R) expression in women with serous ovarian cancer. Our results suggest that strong expression of EGF-R may be a prognostic of prognostic value in women operated because of serous cancer of ovaries.